The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glucose Injection Market Research Report 2025
Synopsis
Glucose Injection solution is used in hospitalized patients for nutrition support, to treat low blood sugar, and to decrease high potassium levels in the blood.
The global Glucose Injection market was valued at US$ 3140 million in 2023 and is anticipated to reach US$ 6531.5 million by 2030, witnessing a CAGR of 10.8% during the forecast period 2024-2030.
According to the "Global Use of Medicines 2023" released by IQVIA Institute, global pharmaceutical expenditures in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and are forecast to grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America and Japan are expected to grow at a slower rate in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America and Eastern Europe will grow strongly. In terms of drug spending, China's drug spending in 2022 will be approximately US$166 billion. It is expected that drug expenditures will only increase in the next few years: from the perspective of demand, the trend of population aging, the increase in residents' wealth and the improvement of health awareness will drive the demand for drugs; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has been elevated to a national strategy; from the perspective of industry policies, it has experienced the uncertainty caused by the early stage of pharmaceutical reform, the implementation of centralized procurement policies and the revision of the drug reimbursement catalog The update will gradually achieve a dynamic balance with multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the public.
This report aims to provide a comprehensive presentation of the global market for Glucose Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucose Injection.
Report Scope
The Glucose Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucose Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucose Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Amphastar
ChanGee
HAIXIN
SSY Group
CR Double-Cran
Otsuka
B. Braun Medical Inc
ICU Medical
Baxter
Fresenius Kabi
Segment by Type
5% Injection
10% Injection
50% Injection
70% Injection
Other
Segment by Application
Sports
First-Aid Treatment
Trophotherapy
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucose Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucose Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glucose Injection solution is used in hospitalized patients for nutrition support, to treat low blood sugar, and to decrease high potassium levels in the blood.
The global Glucose Injection market was valued at US$ 3140 million in 2023 and is anticipated to reach US$ 6531.5 million by 2030, witnessing a CAGR of 10.8% during the forecast period 2024-2030.
According to the "Global Use of Medicines 2023" released by IQVIA Institute, global pharmaceutical expenditures in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and are forecast to grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America and Japan are expected to grow at a slower rate in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America and Eastern Europe will grow strongly. In terms of drug spending, China's drug spending in 2022 will be approximately US$166 billion. It is expected that drug expenditures will only increase in the next few years: from the perspective of demand, the trend of population aging, the increase in residents' wealth and the improvement of health awareness will drive the demand for drugs; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has been elevated to a national strategy; from the perspective of industry policies, it has experienced the uncertainty caused by the early stage of pharmaceutical reform, the implementation of centralized procurement policies and the revision of the drug reimbursement catalog The update will gradually achieve a dynamic balance with multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the public.
This report aims to provide a comprehensive presentation of the global market for Glucose Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucose Injection.
Report Scope
The Glucose Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucose Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucose Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Amphastar
ChanGee
HAIXIN
SSY Group
CR Double-Cran
Otsuka
B. Braun Medical Inc
ICU Medical
Baxter
Fresenius Kabi
Segment by Type
5% Injection
10% Injection
50% Injection
70% Injection
Other
Segment by Application
Sports
First-Aid Treatment
Trophotherapy
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucose Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucose Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glucose Injection Market Overview
1.1 Product Overview and Scope of Glucose Injection
1.2 Glucose Injection Segment by Type
1.2.1 Global Glucose Injection Market Value Comparison by Type (2024-2030)
1.2.2 5% Injection
1.2.3 10% Injection
1.2.4 50% Injection
1.2.5 70% Injection
1.2.6 Other
1.3 Glucose Injection Segment by Application
1.3.1 Global Glucose Injection Market Value by Application: (2024-2030)
1.3.2 Sports
1.3.3 First-Aid Treatment
1.3.4 Trophotherapy
1.3.5 Other
1.4 Global Glucose Injection Market Size Estimates and Forecasts
1.4.1 Global Glucose Injection Revenue 2019-2030
1.4.2 Global Glucose Injection Sales 2019-2030
1.4.3 Global Glucose Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glucose Injection Market Competition by Manufacturers
2.1 Global Glucose Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glucose Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glucose Injection Average Price by Manufacturers (2019-2024)
2.4 Global Glucose Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucose Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucose Injection, Product Type & Application
2.7 Glucose Injection Market Competitive Situation and Trends
2.7.1 Glucose Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucose Injection Players Market Share by Revenue
2.7.3 Global Glucose Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucose Injection Retrospective Market Scenario by Region
3.1 Global Glucose Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glucose Injection Global Glucose Injection Sales by Region: 2019-2030
3.2.1 Global Glucose Injection Sales by Region: 2019-2024
3.2.2 Global Glucose Injection Sales by Region: 2025-2030
3.3 Global Glucose Injection Global Glucose Injection Revenue by Region: 2019-2030
3.3.1 Global Glucose Injection Revenue by Region: 2019-2024
3.3.2 Global Glucose Injection Revenue by Region: 2025-2030
3.4 North America Glucose Injection Market Facts & Figures by Country
3.4.1 North America Glucose Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glucose Injection Sales by Country (2019-2030)
3.4.3 North America Glucose Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glucose Injection Market Facts & Figures by Country
3.5.1 Europe Glucose Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glucose Injection Sales by Country (2019-2030)
3.5.3 Europe Glucose Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucose Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Glucose Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glucose Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Glucose Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glucose Injection Market Facts & Figures by Country
3.7.1 Latin America Glucose Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glucose Injection Sales by Country (2019-2030)
3.7.3 Latin America Glucose Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucose Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucose Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glucose Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glucose Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucose Injection Sales by Type (2019-2030)
4.1.1 Global Glucose Injection Sales by Type (2019-2024)
4.1.2 Global Glucose Injection Sales by Type (2025-2030)
4.1.3 Global Glucose Injection Sales Market Share by Type (2019-2030)
4.2 Global Glucose Injection Revenue by Type (2019-2030)
4.2.1 Global Glucose Injection Revenue by Type (2019-2024)
4.2.2 Global Glucose Injection Revenue by Type (2025-2030)
4.2.3 Global Glucose Injection Revenue Market Share by Type (2019-2030)
4.3 Global Glucose Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glucose Injection Sales by Application (2019-2030)
5.1.1 Global Glucose Injection Sales by Application (2019-2024)
5.1.2 Global Glucose Injection Sales by Application (2025-2030)
5.1.3 Global Glucose Injection Sales Market Share by Application (2019-2030)
5.2 Global Glucose Injection Revenue by Application (2019-2030)
5.2.1 Global Glucose Injection Revenue by Application (2019-2024)
5.2.2 Global Glucose Injection Revenue by Application (2025-2030)
5.2.3 Global Glucose Injection Revenue Market Share by Application (2019-2030)
5.3 Global Glucose Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Glucose Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Amphastar
6.2.1 Amphastar Corporation Information
6.2.2 Amphastar Description and Business Overview
6.2.3 Amphastar Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amphastar Glucose Injection Product Portfolio
6.2.5 Amphastar Recent Developments/Updates
6.3 ChanGee
6.3.1 ChanGee Corporation Information
6.3.2 ChanGee Description and Business Overview
6.3.3 ChanGee Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ChanGee Glucose Injection Product Portfolio
6.3.5 ChanGee Recent Developments/Updates
6.4 HAIXIN
6.4.1 HAIXIN Corporation Information
6.4.2 HAIXIN Description and Business Overview
6.4.3 HAIXIN Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HAIXIN Glucose Injection Product Portfolio
6.4.5 HAIXIN Recent Developments/Updates
6.5 SSY Group
6.5.1 SSY Group Corporation Information
6.5.2 SSY Group Description and Business Overview
6.5.3 SSY Group Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SSY Group Glucose Injection Product Portfolio
6.5.5 SSY Group Recent Developments/Updates
6.6 CR Double-Cran
6.6.1 CR Double-Cran Corporation Information
6.6.2 CR Double-Cran Description and Business Overview
6.6.3 CR Double-Cran Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CR Double-Cran Glucose Injection Product Portfolio
6.6.5 CR Double-Cran Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Glucose Injection Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 B. Braun Medical Inc
6.8.1 B. Braun Medical Inc Corporation Information
6.8.2 B. Braun Medical Inc Description and Business Overview
6.8.3 B. Braun Medical Inc Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 B. Braun Medical Inc Glucose Injection Product Portfolio
6.8.5 B. Braun Medical Inc Recent Developments/Updates
6.9 ICU Medical
6.9.1 ICU Medical Corporation Information
6.9.2 ICU Medical Description and Business Overview
6.9.3 ICU Medical Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ICU Medical Glucose Injection Product Portfolio
6.9.5 ICU Medical Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baxter Glucose Injection Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 Fresenius Kabi
6.11.1 Fresenius Kabi Corporation Information
6.11.2 Fresenius Kabi Glucose Injection Description and Business Overview
6.11.3 Fresenius Kabi Glucose Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fresenius Kabi Glucose Injection Product Portfolio
6.11.5 Fresenius Kabi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucose Injection Industry Chain Analysis
7.2 Glucose Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucose Injection Production Mode & Process
7.4 Glucose Injection Sales and Marketing
7.4.1 Glucose Injection Sales Channels
7.4.2 Glucose Injection Distributors
7.5 Glucose Injection Customers
8 Glucose Injection Market Dynamics
8.1 Glucose Injection Industry Trends
8.2 Glucose Injection Market Drivers
8.3 Glucose Injection Market Challenges
8.4 Glucose Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Glucose Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Glucose Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Glucose Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Glucose Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Glucose Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Glucose Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Glucose Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Glucose Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Glucose Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Glucose Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glucose Injection, Product Type & Application
Table 12. Global Key Manufacturers of Glucose Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glucose Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucose Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glucose Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Glucose Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Glucose Injection Sales Market Share by Region (2019-2024)
Table 19. Global Glucose Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Glucose Injection Sales Market Share by Region (2025-2030)
Table 21. Global Glucose Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Glucose Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Glucose Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Glucose Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Glucose Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Glucose Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Glucose Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Glucose Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Glucose Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Glucose Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Glucose Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Glucose Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Glucose Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Glucose Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Glucose Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Glucose Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Glucose Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Glucose Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Glucose Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Glucose Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Glucose Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Glucose Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Glucose Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Glucose Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Glucose Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Glucose Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Glucose Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Glucose Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Glucose Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Glucose Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Glucose Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Glucose Injection Sales Market Share by Type (2019-2024)
Table 53. Global Glucose Injection Sales Market Share by Type (2025-2030)
Table 54. Global Glucose Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Glucose Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Glucose Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Glucose Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Glucose Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Glucose Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Glucose Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Glucose Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Glucose Injection Sales Market Share by Application (2019-2024)
Table 63. Global Glucose Injection Sales Market Share by Application (2025-2030)
Table 64. Global Glucose Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Glucose Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Glucose Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Glucose Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Glucose Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Glucose Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Glucose Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Amphastar Corporation Information
Table 76. Amphastar Description and Business Overview
Table 77. Amphastar Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Amphastar Glucose Injection Product
Table 79. Amphastar Recent Developments/Updates
Table 80. ChanGee Corporation Information
Table 81. ChanGee Description and Business Overview
Table 82. ChanGee Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. ChanGee Glucose Injection Product
Table 84. ChanGee Recent Developments/Updates
Table 85. HAIXIN Corporation Information
Table 86. HAIXIN Description and Business Overview
Table 87. HAIXIN Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. HAIXIN Glucose Injection Product
Table 89. HAIXIN Recent Developments/Updates
Table 90. SSY Group Corporation Information
Table 91. SSY Group Description and Business Overview
Table 92. SSY Group Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. SSY Group Glucose Injection Product
Table 94. SSY Group Recent Developments/Updates
Table 95. CR Double-Cran Corporation Information
Table 96. CR Double-Cran Description and Business Overview
Table 97. CR Double-Cran Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. CR Double-Cran Glucose Injection Product
Table 99. CR Double-Cran Recent Developments/Updates
Table 100. Otsuka Corporation Information
Table 101. Otsuka Description and Business Overview
Table 102. Otsuka Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Otsuka Glucose Injection Product
Table 104. Otsuka Recent Developments/Updates
Table 105. B. Braun Medical Inc Corporation Information
Table 106. B. Braun Medical Inc Description and Business Overview
Table 107. B. Braun Medical Inc Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. B. Braun Medical Inc Glucose Injection Product
Table 109. B. Braun Medical Inc Recent Developments/Updates
Table 110. ICU Medical Corporation Information
Table 111. ICU Medical Description and Business Overview
Table 112. ICU Medical Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. ICU Medical Glucose Injection Product
Table 114. ICU Medical Recent Developments/Updates
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Business Overview
Table 117. Baxter Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Baxter Glucose Injection Product
Table 119. Baxter Recent Developments/Updates
Table 120. Fresenius Kabi Corporation Information
Table 121. Fresenius Kabi Description and Business Overview
Table 122. Fresenius Kabi Glucose Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Fresenius Kabi Glucose Injection Product
Table 124. Fresenius Kabi Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Glucose Injection Distributors List
Table 128. Glucose Injection Customers List
Table 129. Glucose Injection Market Trends
Table 130. Glucose Injection Market Drivers
Table 131. Glucose Injection Market Challenges
Table 132. Glucose Injection Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glucose Injection
Figure 2. Global Glucose Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Glucose Injection Market Share by Type in 2023 & 2030
Figure 4. 5% Injection Product Picture
Figure 5. 10% Injection Product Picture
Figure 6. 50% Injection Product Picture
Figure 7. 70% Injection Product Picture
Figure 8. Other Product Picture
Figure 9. Global Glucose Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Glucose Injection Market Share by Application in 2023 & 2030
Figure 11. Sports
Figure 12. First-Aid Treatment
Figure 13. Trophotherapy
Figure 14. Other
Figure 15. Global Glucose Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Glucose Injection Market Size (2019-2030) & (US$ Million)
Figure 17. Global Glucose Injection Sales (2019-2030) & (K Units)
Figure 18. Global Glucose Injection Average Price (US$/Unit) & (2019-2030)
Figure 19. Glucose Injection Report Years Considered
Figure 20. Glucose Injection Sales Share by Manufacturers in 2023
Figure 21. Global Glucose Injection Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Glucose Injection Players: Market Share by Revenue in 2023
Figure 23. Glucose Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Glucose Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Glucose Injection Sales Market Share by Country (2019-2030)
Figure 26. North America Glucose Injection Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Glucose Injection Sales Market Share by Country (2019-2030)
Figure 30. Europe Glucose Injection Revenue Market Share by Country (2019-2030)
Figure 31. Germany Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Glucose Injection Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Glucose Injection Revenue Market Share by Region (2019-2030)
Figure 38. China Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Glucose Injection Sales Market Share by Country (2019-2030)
Figure 49. Latin America Glucose Injection Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Glucose Injection Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Glucose Injection Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Glucose Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Glucose Injection by Type (2019-2030)
Figure 59. Global Revenue Market Share of Glucose Injection by Type (2019-2030)
Figure 60. Global Glucose Injection Price (US$/Unit) by Type (2019-2030)
Figure 61. Global Sales Market Share of Glucose Injection by Application (2019-2030)
Figure 62. Global Revenue Market Share of Glucose Injection by Application (2019-2030)
Figure 63. Global Glucose Injection Price (US$/Unit) by Application (2019-2030)
Figure 64. Glucose Injection Value Chain
Figure 65. Glucose Injection Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
